Cell-free synthesis of functional antibody fragments to provide a structural basis for antibody–antigen interaction-Reference-Cited by-同舟云学术

Cell-free synthesis of functional antibody fragments to provide a structural basis for antibody–antigen interaction

Published:2018-02-20 Issue:2 Volume:13 Page:e0193158
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Matsuda Takayoshi^ORCID,Ito Takuhiro,Takemoto Chie,Katsura Kazushige,Ikeda Mariko,Wakiyama Motoaki,Kukimoto-Niino Mutsuko,Yokoyama Shigeyuki,Kurosawa Yoshikazu,Shirouzu Mikako

Funder

RIKEN

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Therapeutic antibodies for autoimmunity and inflammation;AC Chan;Nat Rev Immunol,2010

2. Potent antibody therapeutics by design;PJ Carter;Nat Rev Immunol,2006

3. ERBB receptors and cancer: the complexity of targeted inhibitors;NE Hynes;Nat Rev Cancer,2005

4. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors;AW Burgess;Mol Cell,2003

5. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab;S Li;Cancer Cell,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics;Protein Science;2024-09-14

2. Enabling site-specific NMR investigations of therapeutic Fab using a cell-free based isotopic labeling approach: application to anti-LAMP1 Fab;Journal of Biomolecular NMR;2024-03-28

3. Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma;Applied Biochemistry and Biotechnology;2023-03-28

4. Targeting Ras-binding domain of ELMO1 by computational nanobody design;Communications Biology;2023-03-17

5. Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models;iScience;2022-12